Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2012

01-10-2012 | Article

Evaluation of the prognosis of fulminant viral hepatitis in late pregnancy by the MELD scoring system

Authors: Y. Yang, L. Deng, X. Li, Z. Shi, D. Chen, X. Chen, M. Li, L. Ma

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2012

Login to get access

Abstract

The purpose of this paper was to analyze the prognosis of women with fulminant viral hepatitis in late pregnancy (FVHILP) by the Model for End-Stage Liver Disease (MELD) scoring system. A retrospective study involving patients admitted to two tertiary hospitals between January 1, 1994 and June 30, 2011 was undertaken. The relations between MELD scores and change of MELD score over time (ΔMELD) and prognosis during hospitalization were analyzed. Among the 54 patients with FVHILP, the MELD scores on admission were significantly higher in the non-survival group than those in the survival group (p < 0.05). Among the 26 FVHILP patients who underwent cesarean section, the MELD scores before and after cesarean section were both significantly higher in the non-survival group (p < 0.05). The ΔMELD scores (before operation and three days after operation) significantly increased in the non-survival group (p < 0.05). The concordance (c-statistic) values were all greater than 0.8. The MELD scoring system shows excellent short-term predictive value for the prognosis of FVHILP.
Literature
1.
Bernuau J, Rueff B, Benhamou JP (1986) Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 6:97–106PubMedCrossRef
2.
Khuroo MS, Teli MR, Skidmore S, Sofi MA, Khuroo MI (1981) Incidence and severity of viral hepatitis in pregnancy. Am J Med 70:252–255PubMedCrossRef
3.
Li XM, Ma L, Yang YB, Shi ZJ, Zhou SS (2005) Clinical characteristics of fulminant hepatitis in pregnancy. World J Gastroenterol 11:4600–4603PubMed
4.
5.
Jashnani KD, Rupani AB, Wani RJ (2009) Maternal mortality: an autopsy audit. J Postgrad Med 55:12–16PubMedCrossRef
6.
Ujah IA, Aisien OA, Mutihir JT, Vanderjagt DJ, Glew RH, Uguru VE (2005) Factors contributing to maternal mortality in north-central Nigeria: a seventeen-year review. Afr J Reprod Health 9:27–40PubMedCrossRef
7.
Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D’Amico G, Dickson ER, Kim WR (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33:464–470PubMedCrossRef
8.
Kamath PS, Kim WR, Advanced Liver Disease Study Group (2007) The model for end-stage liver disease (MELD). Hepatology 45:797–805PubMedCrossRef
9.
Salerno F, Merli M, Cazzaniga M, Valeriano V, Rossi P, Lovaria A, Meregaglia D, Nicolini A, Lubatti L, Riggio O (2002) MELD score is better than Child–Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 36:494–500PubMedCrossRef
10.
Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, Wolfe RA, Krom R, United Network for Organ Sharing Liver Disease Severity Score Committee (2003) Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124:91–96PubMedCrossRef
11.
Botta F, Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B, Testa E, Risso D, Colla G, Testa R (2003) MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut 52:134–139PubMedCrossRef
12.
Li XM, Ma L, Yang YB, Shi ZJ, Zhou SS (2005) Prognostic factors of fulminant hepatitis in pregnancy. Chin Med J (Engl) 118:1754–1757
13.
Joshi D, James A, Quaglia A, Westbrook RH, Heneghan MA (2010) Liver disease in pregnancy. Lancet 375:594–605PubMedCrossRef
14.
Liu H, Hu J, Cai Q, Liu T (2000) Research progress of effective anti-hepatitis B virus components of Chinese medicine. Pharm J Chin PLA 16:265–267
15.
16.
17.
Yu JW, Wang GQ, Zhao YH, Sun LJ, Wang SQ, Li SC (2007) The MELD scoring system for predicting prognosis in patients with severe hepatitis after plasma exchange treatment. Hepatobiliary Pancreat Dis Int 6:492–496PubMed
18.
Qian ZP, Liao YB, Wang JF, Wu SM (2006) The evaluating function of MELD scoring system on prognosis of patients with chronic severe hepatitis B. Gan Zang 11:316–317
19.
Zhou J, He WF, Tang XE (2007) Analysis of short-term prognosis on patients with chronic severe hepatitis B using the Model for End-stage Liver Disease. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 19:416–418PubMed
20.
Chen RL, Luo RH, Chong YT, Wu YK, Zhao ZX, Gao ZL (2006) The value of MELD scoring system on short-term prognosis of patients with chronic severe hepatitis B. Zhongshan Da Xue Xue Bao (Yi Xue Ke Xue Ban) 27:594–595
21.
Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG (2005) Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 11:336–343PubMedCrossRef
22.
Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G (2006) Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 130:1652–1660PubMedCrossRef
23.
Wong ZH, Cai SQ (2005) Analysis of prognosis on patients with severe viral hepatitis using the Model for End-stage Liver Disease. Zhonghua Gan Zang Bing Za Zhi 13:249–251PubMed
24.
Bambha K, Kim WR, Kremers WK, Therneau TM, Kamath PS, Wiesner R, Rosen CB, Thostenson J, Benson JT, Dickson ER (2004) Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant 4:1798–1804PubMedCrossRef
25.
Zhao YQ, Hu XB, Li YP, Zhou Y (2004) Analysis of MELD scoring system on chronic severe hepatitis. Xiandai Linchuang Yixue Shengwu Gongchengxue Zazhi 10:396–397
26.
27.
Naiki T, Nakayama N, Mochida S, Oketani M, Takikawa Y, Suzuki K, Tada SI, Ichida T, Moriwaki H, Tsubouchi H, the Intractable Hepato-Biliary Disease Study Group supported by the Ministry of Health, Labor and Welfare of Japan (2012) Novel scoring system as a useful model to predict the outcome of patients with acute liver failure: application to indication criteria for liver transplantation. Hepatol Res 42:68–75PubMedCrossRef
28.
Bie CQ, Yang DH, Tang SH, Huang W (2009) The value of model for end-stage liver disease and Child–Turcotte–Pugh scores over time in evaluating the prognosis of patients with decompensated cirrhosis: experience in the Chinese mainland. Hepatol Res 39:779–785PubMedCrossRef
29.
Shi Z, Yang Y, Ma L, Li X, Schreiber A (2010) Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Obstet Gynecol 116:147–159PubMedCrossRef
30.
Shi Z, Li X, Ma L, Yang Y (2010) Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission—a meta-analysis. Int J Infect Dis 14:e622–e634PubMedCrossRef
31.
Yang Y, Deng L, Li X, Shi Z, Jiang P, Chen D, Yu Y, Wang Z, Tang X, Zhao S, Feng L, Tan H, Ma L (2011) Analysis of prognosis-associated factors in fulminant viral hepatitis during pregnancy in China. Int J Gynaecol Obstet 114:242–245PubMedCrossRef
Metadata
Title
Evaluation of the prognosis of fulminant viral hepatitis in late pregnancy by the MELD scoring system
Authors
Y. Yang
L. Deng
X. Li
Z. Shi
D. Chen
X. Chen
M. Li
L. Ma
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2012
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1613-y

Other articles of this Issue 10/2012

European Journal of Clinical Microbiology & Infectious Diseases 10/2012 Go to the issue

Article

Prospective evaluation of clinical scoring systems in infants with bronchiolitis admitted to the intensive care unit

Article

Emergence of multidrug-resistant NDM-1-producing Gram-negative bacteria in Bangladesh

Article

Performance of a novel microarray multiplex PCR for the detection of 23 respiratory pathogens (SYMP-ARI study)

Article

The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model

Article

Pediatric osteoarticular infections caused by Streptococcus pneumoniae before and after the introduction of the heptavalent pneumococcal conjugate vaccine

Review

The effect of biomaterials and antifungals on biofilm formation by Candida species: a review
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits